Skip to the page

Data / Form D filings / Chorda Pharma, Inc.

Chorda Pharma, Inc.: Form D filings

Chorda Pharma, Inc., a pharmaceuticals company in Roanoke, VA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on December 20, 2024, reports $200,000 sold of a $600,000 offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
709 S JEFFERSON STREET, SUITE 301, Roanoke, VA, 24016
Phone
(540) 632-0679
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Virginia
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1906254

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 20, 2024New notice$600,000$200,000$400,0004Dec 6, 2024sec.gov
Apr 26, 2022Amendment$500,000$292,500$207,50013Dec 17, 2021sec.gov
Feb 1, 2022New notice$500,000$292,500$207,50013Dec 17, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
George Robert Vaughan, Jr.Director
Aileen B HelselDirector
Richard CarlissExecutive Officer, Director, Promoter
John B Williamson IIIDirector
Victor IannelloExecutive Officer, Director, Promoter

Other pharmaceuticals companies in Virginia that filed recently

Every Form D from the week of Dec 16, 2024 · All recent filings in Virginia · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Chorda Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.